DAPK hypermethylation has been detected through MSP investigation in 19% of metastatic tumor tissues from stage III/IV melanoma patients [76] and in only 5% of uveal melanoma tissues (real-time quantitative MSP analysis) [77]. This evidence concerns the gene DAPK1 and melanoma.